Cargando…

Two Moral Arguments for a Global Social Cost of Carbon

Detalles Bibliográficos
Autor principal:	Mintz-Woo, Kian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Routledge 2018
Materias:	Open Peer Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5958921/ https://www.ncbi.nlm.nih.gov/pubmed/29862129 http://dx.doi.org/10.1080/21550085.2018.1448038

Ejemplares similares

The Determination of Quality of Life and Medical Futility in Disorders of Consciousness: Reinterpreting the Moral Code of Islam
por: Rady, Mohamed Y., et al.
Publicado: (2015)

Justice and Global Health Research
por: Venkatapuram, Sridhar
Publicado: (2016)

“The Danger of Lurking”: Different Conceptualizations of “User Awareness” in Social Media Research
por: Samuel, Gabrielle
Publicado: (2017)

What's in a Name? The Politics of ‘Precision Medicine’
por: Chan, Sarah, et al.
Publicado: (2018)

Domains of Well-Being in Minimally Conscious Patients: Illuminating a Persistent Problem
por: Graham, Mackenzie
Publicado: (2018)

In Defense of Best Interests: When Parents and Clinicians Disagree
por: Coulson-Smith, Peta, et al.
Publicado: (2018)

Open peer review commentary on building clinically relevant outcomes across the Alzheimer's disease spectrum
por: Rockwood, Kenneth
Publicado: (2021)

Meaningful benefit and minimal clinically important difference (MCID) in Alzheimer's disease: Open peer commentary
por: Cummings, Jeffrey
Publicado: (2023)

Open peer commentary on “Prescribing anti‐amyloid immunotherapies to treat Alzheimer's disease: Fully informing patient decisions”
por: Gandy, Sam
Publicado: (2023)

Immune moral models? Pro-social rule breaking as a moral enhancement approach for ethical AI
por: Ramanayake, Rajitha, et al.
Publicado: (2022)

A moral dilemma argument against clinical trials of incentives for kidney donation
por: Prasad, G. V. Ramesh
Publicado: (2015)

Two kinds of rule regulating human subjects research
por: Sachs, Benjamin
Publicado: (2015)

Yesterday's war; tomorrow's technology: peer commentary on ‘Ethical, legal, social and policy issues in the use of genomic technologies by the US military’
por: Evans, Nicholas G., et al.
Publicado: (2014)

THE CERN MODEL, UNITED NATIONS AND GLOBAL PUBLIC GOODS: addressing global challenges
por: Tolosa, Eva
Publicado: (2015)

Precision medicine: a matter of regulation or collaboration?
por: Knoppers, Bartha Maria
Publicado: (2016)

The Genetic Sphygmomanometer: an argument for routine genome-wide genotyping in the population and a new view on its use to inform clinical practice
por: Timpson, Nicholas John, et al.
Publicado: (2018)

Commentary: Is there a problem Consent in Escrow can solve?
por: Taylor, Holly A.
Publicado: (2015)

Assessing health-state utility: is there a uniquely privileged perspective?
por: Wasserman, David
Publicado: (2020)

Neuroscience cannot answer these questions: a response to G. and R. Murrow's essay hypothesizing a link between dehumanization, human rights abuses and public policy
por: Hoffman, Morris B.
Publicado: (2015)

The patent law Duchy of Grand Fenwick: a comment on The mouse that trolled: the long and tortuous history of a gene mutation patent that became an expensive impediment to Alzheimer's research
por: Sarnoff, Joshua D.
Publicado: (2015)

Uterus transplantation: does procreative liberty encompass a right to gestate?
por: Alghrani, Amel
Publicado: (2016)

Informed consent to participation in interventional studies: second-order in a different sense
por: Eyal, Nir
Publicado: (2015)

Peer commentary: in vitro gametogenesis: just another way to have a baby
por: Carbone, June
Publicado: (2016)

‘No, actually your life is going considerably worse’: a comment on Nir Eyal
por: Enoch, David
Publicado: (2020)

Regulating drug promotion to promote the public health: a response to Bennett et al.
por: Zettler, Patricia J.
Publicado: (2015)

We should not vaccinate the young to protect the old: a response to Giubilini, Savulescu, and Wilkinson
por: de Miguel Beriain, Iñigo
Publicado: (2021)

A problem not yet manifest: gaps in insurance coverage of medical interventions after genetic testing
por: Malanga, Sarah, et al.
Publicado: (2015)

Reporting, recording, and communication of COVID-19 cases in workplace: data protection as a moving target
por: Shabani, Mahsa, et al.
Publicado: (2020)

What do experimental simulations tell us about the effect of neuro/genetic evidence on jurors?
por: Scurich, Nicholas
Publicado: (2018)

Is it ‘gene therapy’?
por: Sherkow, Jacob S, et al.
Publicado: (2018)

Science wars—How much risk should soldiers be exposed to in military experimentation?
por: Savulescu, Julian
Publicado: (2015)

Dehumanization: its operations and its origins
por: Simpson, Robert Mark
Publicado: (2015)

Orphan drug incentives in the pharmacogenomic context: policy responses in the USA and Canada
por: Herder, Matthew
Publicado: (2016)

Hate speech, volition, and neurology
por: Roginsky, Alexandra B., et al.
Publicado: (2015)

Buttressing regulation of cognitive enhancement devices with principles of harm reduction
por: Fitz, Nicholas S., et al.
Publicado: (2014)

Regulation of cognitive enhancement devices: commentary
por: Johnson, Reuben, et al.
Publicado: (2014)

Medical regulation of cognitive enhancement devices: some concerns
por: King, Mike, et al.
Publicado: (2014)

The brain, cognitive enhancement devices, and European regulation
por: Kuersten, Andreas, et al.
Publicado: (2014)

Outstanding questions concerning the regulation of cognitive enhancement devices
por: De Ridder, Dirk, et al.
Publicado: (2014)

Environmental neuroethics: changing the environment—changing the brain Recommendations submitted to the Presidential Commission for the Study of Bioethical Issues
por: Illes, Judy, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_rig42mib36g9j5lpi9u2029b36